European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 331-334 , April 2010

Adjuvant chest wall radiotherapy for breast cancer: Black, white and shades of grey

  • I. Kunkler

      Affiliations

    • Corresponding Author InformationTel.: +44 131 537 2214; fax: +44 131 537 1470.

,Accepted 9 November 2009.

References 

  1. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955
  3. Overgaard M, Jensen MB, Overgaard J, et al. Randomised trial evaluating postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Results of the DBCG 82c trial. Lancet. 1999;353:1043–1048
  4. Paterson R, Russell MH. Clinical trials in malignant disease. Part III breast cancer: evaluation of postoperative radiotherapy. J Fac Radiol (London). 1959;10:17
  5. Elston CW, Gresham GA, Rao GS, et al. The cancer research campaign (King's/Cambridge trial for early breast cancer). Br J Cancer. 1982;45:655–669
  6. Kyndi M, Overgaard M, Nielsen HM, et al. High local recurrence is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82b&c. Radiother Oncol. 2009;90:74–79
  7. Cuzick J, Stewart HJ, Peto R, et al. Overview of randomised trials of postoperative radiotherapy in breast cancer. Cancer Treat Rep. 1987;1:15–29
  8. Levitt SH, Fletcher GH. Trials and tribulations: do clinical trials prove that irradiation increases cardiac and secondary cancer mortality in the breast cancer patient?. Int J Rad Oncol Biol Phys. 1991;20:523–527
  9. Cuzick J, Stewart HJ, Rutqvist I, et al. Cause-specific mortality in longterm survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:1444–1455
  10. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995;333:1444–1455
  11. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757–1770
  12. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  13. Chung CS, Harris JR. Post-mastectomy radiation therapy: translating local benefits into improved survival. Breast. 2007;S78–S83
  14. Hojris I, Overgaard M, Christensen JJ, et al. Morbidity and mortality of ischaemic heart disease in high-risk breast cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c trials. Lancet. 1999;354:1425–1430
  15. Goldhirsch A, Coates AS, Colleoni M, et al. Radiotherapy and chemotherapy in high risk breast cancer. N Engl J Med. 1998;338:330–331
  16. Recht A, Bartelink H, Fourquet A, et al. Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol. 1998;16:2886–2889
  17. Harris J, Halpin-Murphy P, McNeese M, et al. Consensus statement on postmastectomy radiation therapy. Int J Rad Oncol Biol Phys. 1999;44:989–990
  18. Recht A, Edge S, Solin L, et al. Postmastectomy radiotherapy guidelines of the American Society of clinical oncology. J Clin Oncol. 2001;19:1539–1569
  19. Goldhirsch A, Wood WC, Gelver RD et al. In: 10th St Gallen Conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer, vol. 18; 2007. p. 1133–44.
  20. Marks LB, Zeng J, Prosnitz LR. One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol. 2008;26:2075–2077
  21. Russell NS, Kunkler IH, van Tienhoven G, et al. Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?. J Clin Oncol. 2008;7:996–997
  22. Pierce LJ. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol. 2005;8:1706–1717
  23. Ragaz J, Jackson S, Le N, et al. Survival gains of loco-regional radiation (RT) in breast cancer with 1–3 positive axillary nodes (N1-3): loco-regional recurrences (LocRecs) are NOT a useful guide to predict the benefit of RT- An update from the British Columbia (BC) randomised trial. Proc Am Soc Clin Oncol. 2000;19:82a;(abst 312)
  24. Kunkler IH, Canney P, van Tienhoven G, et al. On behalf of the MRC/EORTC (BIG 2-04) SUPREMO Trial Management Group Elucidating the role of chest wall irradiation in ‘Intermediate-risk’ breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol. 2008;20:31–34
  25. Overgaard M, Nielsen HM, Overgaard J, et al. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82b&c randomised trials. Radiother Oncol. 2007;82:247–253
  26. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol. 2007;84:84–101
  27. Recht A, Gray R, Davidson N, et al. Loco-regional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  28. Early and advanced breast cancer: diagnosis and treatment. NICE clinical guideline. NICE guideline 80. London: National Institute for Clinical Excellence; February 2009;p. 75
  29. Kyndi M, Sorensen FB, Knudsen H, et al. Estrogen receptor, progesterone receptor, HER-2 and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419–1426
  30. Nuyten DS, Kreike B, Hart AA, et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res. 2006;8:R62
  31. Yu JB, Wilson LD, Dasgupta T, et al. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI surveillance, epidemiology, and end results database. Cancer. 2008;113:38–47
  32. Carlson RW, Anderson BO, Burnstein HJ, et al. NCCN breast cancer clinical practice guidelines in oncology. Version 1. Available at: http://www.nccn.org/professionals/physicians_gls/PDT/breast pdf2007;
  33. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126

PII: S0748-7983(09)00512-5

doi: 10.1016/j.ejso.2009.11.004

European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 331-334 , April 2010

Article Tools